AbbVie, Inc.

Registered Principal Details

Business Or Interest:
Pharmaceutical Research and Development

Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.

CEO Name:
Richard Gonzalez
Director, State Government Affairs

Contact
YB
Yvonne Barton
14900 Avery Ranch Blvd., Suite C200-211
Austin, TX 78717
(847) 502-6060
yvonne.barton@abbvie.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Christina Lechter Exclusive Duties No Authorized On 12/21/2020 Withdrawn On 4/23/2021
William J McCoshen Exclusive Duties Yes Authorized On 12/21/2020 Withdrawn On N/A
Tony Langenohl Exclusive Duties Yes Authorized On 2/8/2021 Withdrawn On N/A
Christina Lechter Exclusive Duties No Authorized On 8/13/2021 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 184
Assembly Bill 184
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.

Bill Text and History

For
Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 215
Senate Bill 215
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.

Bill Text and History

For
Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Budget Bill Subjects

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health Services: Medicaid Services
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services

Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Insurance: Departmentwide
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide

Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Insurance: Supervision of the Insurance Industry
Biennial budget bill treatment of matter relating to
Insurance: Supervision of the Insurance Industry

Notification Date
3/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Development, drafting or introduction of a proposal relating to drug affordability and accessibility
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to drug affordability and accessibility

Action Intended To Affect
Legislative matter

Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage

Action Intended To Affect
Legislative matter

Notification Date
3/2/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2021
January - June
2021
July - December
Total
Total Lobbying Expenditures 2021
January - June
$29,175.00
2021
July - December
$31,875.00
Total $61,050.00
Total Hours Communicating 2021
January - June
21.00
2021
July - December
52.00
Total 73.00
Total Hours Other 2021
January - June
53.00
2021
July - December
96.50
Total 149.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
36 %
2021
July - December
43 %
2022
January - June
2022
July - December
Total 41 %
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
36 %
2021
July - December
43 %
2022
January - June
2022
July - December
Total 41 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
28 %
2021
July - December
7 %
2022
January - June
2022
July - December
Total 14 %
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
7 %
2022
January - June
2022
July - December
Total 5 %

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures